JP Morgan Chase’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.2M | Buy |
80,180
+24,880
| +45% | +$7.7M | ﹤0.01% | 1983 |
|
|
2025
Q4 | $16.3M | Buy |
55,300
+29,092
| +111% | +$5.42M | ﹤0.01% | 2239 |
|
|
2025
Q3 | $1.39M | Buy |
26,208
+12,270
| +88% | +$595K | ﹤0.01% | 4349 |
|
|
2025
Q2 | $586K | Buy |
13,938
+2,459
| +21% | +$93.6K | ﹤0.01% | 4691 |
|
|
2025
Q1 | $435K | Buy |
11,479
+1,786
| +18% | +$112K | ﹤0.01% | 4866 |
|
|
2024
Q4 | $746K | Buy |
9,693
+1,879
| +24% | +$136K | ﹤0.01% | 4818 |
|
|
2024
Q3 | $450K | Buy |
7,814
+448
| +6% | +$24.2K | ﹤0.01% | 4964 |
|
|
2024
Q2 | $305K | Sell |
7,366
-44,006
| -86% | -$2.08M | ﹤0.01% | 4934 |
|
|
2024
Q1 | $3.13M | Buy |
51,372
+51,355
| +302,088% | +$2.3M | ﹤0.01% | 3480 |
|
|
2023
Q4 | $379 | Sell |
17
-81
| -83% | -$1.46K | ﹤0.01% | 6960 |
|
|
2023
Q3 | $2.5K | Hold |
98
| – | – | ﹤0.01% | 6506 |
|
|
2023
Q2 | $1.69K | Sell |
98
-2,435
| -96% | -$37.3K | ﹤0.01% | 6375 |
|
|
2023
Q1 | $31K | Buy |
2,533
+1,008
| +66% | +$42.5K | ﹤0.01% | 5861 |
|
|
2022
Q4 | $54K | Sell |
1,525
-51
| -3% | -$1.59K | ﹤0.01% | 5598 |
|
|
2022
Q3 | $53K | Buy |
1,576
+77
| +5% | +$3.84K | ﹤0.01% | 5530 |
|
|
2022
Q2 | $55K | Sell |
1,499
-754
| -33% | -$80.5K | ﹤0.01% | 5628 |
|
|
2022
Q1 | $345K | Buy |
2,253
+335
| +17% | +$68.8K | ﹤0.01% | 4912 |
|
|
2021
Q4 | $568K | Buy |
1,918
+383
| +25% | +$112K | ﹤0.01% | 4746 |
|
|
2021
Q3 | $425K | Buy |
1,535
+442
| +40% | +$120K | ﹤0.01% | 4824 |
|
|
2021
Q2 | $300K | Buy |
1,093
+596
| +120% | +$213K | ﹤0.01% | 5016 |
|
|
2021
Q1 | $244K | Buy |
497
+125
| +34% | +$88.9K | ﹤0.01% | 5068 |
|
|
2020
Q4 | $308K | Buy |
+372
| New | +$217K | ﹤0.01% | 4643 |
|
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM